Compositions and methods for treating non-age-associated hearing impairment in a human subject
US12077773B2 · kind B2 · utility
2Cited by
36References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 11, 2023 |
| Grant date | Sep 3, 2024 |
| Priority date | — |
| Expiry date | Oct 11, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2800/50
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are compositions that include at least two different nucleic acid vectors, where each of the at least two different vectors includes a coding sequence that encodes a different portion of an otoferlin protein, and the use of these compositions to treat hearing loss in a subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.